Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Single cell RNA-seq of pancreatic mouse tumors upon treatment


ABSTRACT: KRAS-mutant pancreatic ductal adenocarcinoma (PDAC) is highly immunosuppressive and resistant to targeted therapies, immune checkpoint blockade and engineered T cells. In this study, we performed a systematic high throughput combinatorial drug screen and identified a synergistic interaction between the MEK inhibitor trametinib and the multi- kinase inhibitor nintedanib. Using single cell RNA sequencing and immunophenotyping, we show that the combination therapy reprograms the immunosuppressive microenvironment and primes cytotoxic and memory T cells to infiltrate the tumors, thereby sensitizing mesenchymal PDAC to PD-L1 inhibition.

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Mus musculus

SUBMITTER: Dieter Saur 

PROVIDER: E-MTAB-9954 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2021-01-21 | E-MTAB-9994 | biostudies-arrayexpress
2021-01-25 | E-MTAB-10020 | biostudies-arrayexpress
2023-02-24 | E-MTAB-12615 | biostudies-arrayexpress
2019-07-08 | E-MTAB-7916 | biostudies-arrayexpress
2023-04-15 | E-MTAB-5803 | biostudies-arrayexpress
2023-04-15 | E-MTAB-5806 | biostudies-arrayexpress
2024-09-03 | E-MTAB-14404 | biostudies-arrayexpress
2021-02-02 | E-MTAB-10054 | biostudies-arrayexpress
2024-03-12 | E-MTAB-13816 | biostudies-arrayexpress
2024-03-12 | E-MTAB-13823 | biostudies-arrayexpress